|
JPS58180487U
(ja)
|
1982-05-28 |
1983-12-02 |
松下電工株式会社 |
光線式報知器の組立体
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
JPH053790Y2
(enExample)
|
1988-08-03 |
1993-01-29 |
|
|
|
AU6355090A
(en)
|
1989-08-23 |
1991-04-03 |
Scripps Clinic And Research Foundation |
Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders
|
|
US5256643A
(en)
|
1990-05-29 |
1993-10-26 |
The Government Of The United States |
Human cripto protein
|
|
WO1992007574A1
(en)
|
1990-10-25 |
1992-05-14 |
Tanox Biosystems, Inc. |
Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells
|
|
US5543503A
(en)
|
1991-03-29 |
1996-08-06 |
Genentech Inc. |
Antibodies to human IL-8 type A receptor
|
|
CA2105998C
(en)
|
1991-03-29 |
2003-05-13 |
James Lee |
Human pf4a receptors and their use
|
|
US5440021A
(en)
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
|
JP3050424B2
(ja)
|
1991-07-12 |
2000-06-12 |
塩野義製薬株式会社 |
ヒトエンドセリンリセプター
|
|
US5264557A
(en)
|
1991-08-23 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polypeptide of a human cripto-related gene, CR-3
|
|
US5362852A
(en)
|
1991-09-27 |
1994-11-08 |
Pfizer Inc. |
Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
|
|
US5976551A
(en)
|
1991-11-15 |
1999-11-02 |
Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and method of using the determinant
|
|
US6153408A
(en)
|
1991-11-15 |
2000-11-28 |
Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
|
IL107366A
(en)
|
1992-10-23 |
2003-03-12 |
Chugai Pharmaceutical Co Ltd |
Genes coding for megakaryocyte potentiator
|
|
US5644033A
(en)
|
1992-12-22 |
1997-07-01 |
Health Research, Inc. |
Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment
|
|
US5869445A
(en)
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US5773223A
(en)
|
1993-09-02 |
1998-06-30 |
Chiron Corporation |
Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof
|
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
|
US5750370A
(en)
|
1995-06-06 |
1998-05-12 |
Human Genome Sciences, Inc. |
Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor
|
|
JPH08336393A
(ja)
|
1995-04-13 |
1996-12-24 |
Mitsubishi Chem Corp |
光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
US20020193567A1
(en)
|
1995-08-11 |
2002-12-19 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
|
JP3646191B2
(ja)
|
1996-03-19 |
2005-05-11 |
大塚製薬株式会社 |
ヒト遺伝子
|
|
US6218519B1
(en)
|
1996-04-12 |
2001-04-17 |
Pro-Neuron, Inc. |
Compounds and methods for the selective treatment of cancer and bacterial infections
|
|
AU722499B2
(en)
|
1996-05-17 |
2000-08-03 |
Schering Corporation |
Human B-cell antigens, related reagents
|
|
EP0961619A4
(en)
|
1996-09-27 |
2001-09-26 |
Bristol Myers Squibb Co |
HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US5945511A
(en)
|
1997-02-20 |
1999-08-31 |
Zymogenetics, Inc. |
Class II cytokine receptor
|
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
EP0981541B1
(en)
|
1997-03-10 |
2004-06-02 |
The Regents Of The University Of California |
Psca: prostate stem cell antigen
|
|
US6261791B1
(en)
|
1997-03-10 |
2001-07-17 |
The Regents Of The University Of California |
Method for diagnosing cancer using specific PSCA antibodies
|
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
|
US6555339B1
(en)
|
1997-04-14 |
2003-04-29 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human protein-coupled receptors
|
|
US6319688B1
(en)
|
1997-04-28 |
2001-11-20 |
Smithkline Beecham Corporation |
Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
|
|
WO1998051824A1
(en)
|
1997-05-15 |
1998-11-19 |
Abbott Laboratories |
Reagents and methods useful for detecting disease of the urinary tract
|
|
US6890749B2
(en)
|
1997-05-15 |
2005-05-10 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
US20030060612A1
(en)
|
1997-10-28 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20020034749A1
(en)
|
1997-11-18 |
2002-03-21 |
Billing-Medel Patricia A. |
Reagents and methods useful for detecting diseases of the breast
|
|
US6110695A
(en)
|
1997-12-02 |
2000-08-29 |
The Regents Of The University Of California |
Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
|
|
WO2004031238A2
(en)
|
2002-10-03 |
2004-04-15 |
Mcgill Univeristy |
Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics
|
|
JP4603157B2
(ja)
|
1998-03-13 |
2010-12-22 |
ザ バーナム インスティチュート |
種々の選択された器官または組織にホーミングする分子
|
|
ATE518956T1
(de)
|
1998-05-13 |
2011-08-15 |
Epimmune Inc |
Expressionsvektoren zur stimulierung einer immunantwort und verfahren zu deren verwendung
|
|
US20030064397A1
(en)
|
1998-05-22 |
2003-04-03 |
Incyte Genomics, Inc. |
Transmembrane protein differentially expressed in prostate and lung tumors
|
|
CA2333321A1
(en)
|
1998-05-22 |
1999-12-02 |
Daiichi Pharmaceutical Co., Ltd. |
Drug complex
|
|
US20020187472A1
(en)
|
2001-03-09 |
2002-12-12 |
Preeti Lal |
Steap-related protein
|
|
GB9818732D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collection of compounds
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
WO2000012130A1
(en)
|
1998-08-27 |
2000-03-09 |
Smithkline Beecham Corporation |
Rp105 agonists and antagonists
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
ATE320436T1
(de)
|
1998-08-27 |
2006-04-15 |
Spirogen Ltd |
Dimere pyrrolobenzodiazepine
|
|
JP4689781B2
(ja)
|
1998-09-03 |
2011-05-25 |
独立行政法人科学技術振興機構 |
アミノ酸輸送蛋白及びその遺伝子
|
|
WO2000020579A1
(en)
|
1998-10-02 |
2000-04-13 |
Mcmaster University |
Spliced form of erbb-2/neu oncogene
|
|
US20030091580A1
(en)
|
2001-06-18 |
2003-05-15 |
Mitcham Jennifer L. |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6962980B2
(en)
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6858710B2
(en)
|
1998-12-17 |
2005-02-22 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
JP2002536966A
(ja)
|
1998-12-30 |
2002-11-05 |
ベス・イスラエル・ディーコニス・メディカル・センター・インコーポレーテッド |
カルシウムチャネルファミリーの特徴付け
|
|
JP5164300B2
(ja)
|
1999-01-29 |
2013-03-21 |
コリクサ コーポレイション |
HER−2/neu融合タンパク質
|
|
GB9905124D0
(en)
|
1999-03-05 |
1999-04-28 |
Smithkline Beecham Biolog |
Novel compounds
|
|
US7109292B2
(en)
|
1999-03-08 |
2006-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
|
US7304126B2
(en)
|
1999-05-11 |
2007-12-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6268488B1
(en)
|
1999-05-25 |
2001-07-31 |
Barbas, Iii Carlos F. |
Prodrug activation using catalytic antibodies
|
|
WO2000075655A1
(fr)
|
1999-06-03 |
2000-12-14 |
Takeda Chemical Industries, Ltd. |
Procede de criblage avec cd100
|
|
EP2977063A1
(en)
|
1999-06-25 |
2016-01-27 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
US7589172B2
(en)
|
1999-07-20 |
2009-09-15 |
Genentech, Inc. |
PRO256 polypeptides
|
|
US7297770B2
(en)
|
1999-08-10 |
2007-11-20 |
Genentech, Inc. |
PRO6496 polypeptides
|
|
US7294696B2
(en)
|
1999-08-17 |
2007-11-13 |
Genentech Inc. |
PRO7168 polypeptides
|
|
US6909006B1
(en)
|
1999-08-27 |
2005-06-21 |
Spirogen Limited |
Cyclopropylindole derivatives
|
|
CA2380355A1
(en)
|
1999-09-01 |
2001-03-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030232056A1
(en)
|
1999-09-10 |
2003-12-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20030206918A1
(en)
|
1999-09-10 |
2003-11-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20030129192A1
(en)
|
1999-09-10 |
2003-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
WO2001040309A2
(en)
|
1999-10-29 |
2001-06-07 |
Genentech, Inc. |
Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
|
|
ES2568625T3
(es)
|
1999-11-29 |
2016-05-03 |
The Trustees Of Columbia University In The City Of New York |
Aislamiento de cinco genes novedosos que codifican nuevos melanomas de tipo receptor de Fc implicados en la patogénesis del linfoma/melanoma
|
|
WO2001040269A2
(en)
|
1999-11-30 |
2001-06-07 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of breast cancer
|
|
WO2001041787A1
(en)
|
1999-12-10 |
2001-06-14 |
Epimmune Inc. |
INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
|
|
DE60030769T2
(de)
|
1999-12-23 |
2007-10-25 |
Zymogenetics, Inc., Seattle |
Verfahren zur behandlung von entzündungen
|
|
WO2001046232A2
(en)
|
1999-12-23 |
2001-06-28 |
Zymogenetics, Inc. |
Soluble interleukin-20 receptor
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
NZ502058A
(en)
|
1999-12-23 |
2003-11-28 |
Ovita Ltd |
Isolated mutated nucleic acid molecule for regulation of ovulation rate
|
|
US20040001827A1
(en)
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
ES2270893T3
(es)
|
1999-12-24 |
2007-04-16 |
Genentech, Inc. |
Procedimiento y composiciones para prolongar la vida media de compuestos bioactivos.
|
|
US7294695B2
(en)
|
2000-01-20 |
2007-11-13 |
Genentech, Inc. |
PRO10268 polypeptides
|
|
US20020039573A1
(en)
|
2000-01-21 |
2002-04-04 |
Cheever Martin A. |
Compounds and methods for prevention and treatment of HER-2/neu associated malignancies
|
|
US20030224379A1
(en)
|
2000-01-21 |
2003-12-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
|
AU2001243142A1
(en)
|
2000-02-03 |
2001-08-14 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
US20030104562A1
(en)
|
2000-02-11 |
2003-06-05 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001062794A2
(en)
|
2000-02-22 |
2001-08-30 |
Millennium Pharmaceuticals, Inc. |
18607, a human calcium channel
|
|
US20030219806A1
(en)
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
|
US20040052793A1
(en)
|
2001-02-22 |
2004-03-18 |
Carter Paul J. |
Caspase activivated prodrugs therapy
|
|
US20040005561A1
(en)
|
2000-03-01 |
2004-01-08 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
AU2001245280A1
(en)
|
2000-03-07 |
2001-09-17 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
EP1268526A4
(en)
|
2000-03-24 |
2004-09-08 |
Fahri Saatcioglu |
NEW PROSTATE-SPECIFIC AND TESTIS-SPECIFIC NUCLEIC ACID MOLECULES, POLYPEPTIDES AND DIAGNOSTIC AND THERAPEUTIC PROCEDURES
|
|
AU2001250412A1
(en)
|
2000-03-31 |
2001-10-08 |
Ipf Pharmaceuticals Gmbh |
Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction
|
|
WO2001075177A2
(en)
|
2000-04-03 |
2001-10-11 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tumor markers in ovarian cancer
|
|
AU2001249885A1
(en)
|
2000-04-07 |
2001-10-23 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated known g protein-coupled receptors
|
|
AU2001263105A1
(en)
|
2000-05-18 |
2001-11-26 |
Lexicon Genetics Incorporated |
Human semaphorin homologs and polynucleotides encoding the same
|
|
AU2001274888A1
(en)
|
2000-05-19 |
2001-12-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2001094641A2
(en)
|
2000-06-09 |
2001-12-13 |
Idec Pharmaceuticals Corporation |
Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
|
|
AU2001268471A1
(en)
|
2000-06-16 |
2002-01-02 |
Incyte Genomics, Inc. |
G-protein coupled receptors
|
|
MXPA02012749A
(es)
|
2000-06-30 |
2003-10-06 |
Amgen Inc |
Moleculas semejantes a b7 y sus usos.
|
|
EP1301524A1
(en)
|
2000-06-30 |
2003-04-16 |
Human Genome Sciences, Inc. |
B7-like polynucleotides, polypeptides, and antibodies
|
|
WO2002006339A2
(en)
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US20040044179A1
(en)
|
2000-07-25 |
2004-03-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2002010187A1
(en)
|
2000-07-27 |
2002-02-07 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
|
JP2004505617A
(ja)
|
2000-07-28 |
2004-02-26 |
ヴィッセンバッハ,ウルリヒ |
Trp8、Trp9およびTrp10、癌の新規マーカー
|
|
US7229623B1
(en)
|
2000-08-03 |
2007-06-12 |
Corixa Corporation |
Her-2/neu fusion proteins
|
|
WO2002013847A2
(en)
|
2000-08-14 |
2002-02-21 |
Corixa Corporation |
Methods for diagnosis and therapy of hematological and virus-associated malignancies
|
|
CA2419533A1
(en)
|
2000-08-14 |
2002-02-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
|
|
CA2420140A1
(en)
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
GB0020953D0
(en)
|
2000-08-24 |
2000-10-11 |
Smithkline Beecham Biolog |
Vaccine
|
|
EP1346040A2
(en)
|
2000-09-11 |
2003-09-24 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
US20030119121A1
(en)
|
2000-09-15 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6613567B1
(en)
|
2000-09-15 |
2003-09-02 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of Her-2 expression
|
|
EP1803733B1
(en)
|
2000-09-15 |
2010-03-10 |
ZymoGenetics, Inc. |
Polypeptides comprising the extracellular domains of IL-20RA and/or IL-20RB
|
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
|
AU2001292724B2
(en)
|
2000-09-18 |
2005-05-26 |
Biogen Idec Ma Inc. |
CRIPTO mutant and uses thereof
|
|
US6660742B2
(en)
|
2000-09-19 |
2003-12-09 |
Taiho Pharmaceutical Co. Ltd. |
Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycins
|
|
AU2002215345A1
(en)
|
2000-10-13 |
2002-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
|
WO2002038766A2
(en)
|
2000-11-07 |
2002-05-16 |
Zymogenetics, Inc. |
Human tumor necrosis factor receptor
|
|
US20020150573A1
(en)
|
2000-11-10 |
2002-10-17 |
The Rockefeller University |
Anti-Igalpha-Igbeta antibody for lymphoma therapy
|
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
WO2002061087A2
(en)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
|
|
WO2002054940A2
(en)
|
2001-01-12 |
2002-07-18 |
University Of Medicine & Dentistry Of New Jersey |
Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
|
|
US20030119126A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030119125A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
WO2002059377A2
(en)
|
2001-01-24 |
2002-08-01 |
Protein Design Labs |
Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
|
|
WO2002060317A2
(en)
|
2001-01-30 |
2002-08-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
|
WO2002064775A1
(en)
|
2001-02-12 |
2002-08-22 |
Bionomics Limited |
Identification of genes involved in the tumourigenic process
|
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
WO2002078524A2
(en)
|
2001-03-28 |
2002-10-10 |
Zycos Inc. |
Translational profiling
|
|
US6362331B1
(en)
|
2001-03-30 |
2002-03-26 |
Council Of Scientific And Industrial Research |
Process for the preparation of antitumor agents
|
|
WO2003008537A2
(en)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
US6820011B2
(en)
|
2001-04-11 |
2004-11-16 |
The Regents Of The University Of Colorado |
Three-dimensional structure of complement receptor type 2 and uses thereof
|
|
WO2002083866A2
(en)
|
2001-04-17 |
2002-10-24 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
|
|
EP1463928A2
(en)
|
2001-04-18 |
2004-10-06 |
Protein Design Labs |
Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
|
|
RS20110024A
(sr)
|
2001-04-26 |
2011-08-31 |
Biogen Idec Ma Inc. |
Antitela koja blokiraju cripto i njihova upotreba
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
EP1988097A1
(en)
|
2001-05-09 |
2008-11-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
AU2002344326A1
(en)
|
2001-05-11 |
2002-11-25 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
|
|
CA2448123C
(en)
|
2001-05-24 |
2012-09-11 |
Zymogenetics, Inc. |
Taci-immunoglobulin fusion proteins
|
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
|
JP2005518185A
(ja)
|
2001-06-04 |
2005-06-23 |
キュラジェン コーポレイション |
新規タンパク質およびそれをコード化する核酸
|
|
WO2002098358A2
(en)
|
2001-06-04 |
2002-12-12 |
Eos Biotechnology, Inc. |
Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
|
|
JP2004528046A
(ja)
|
2001-06-05 |
2004-09-16 |
エクセリクシス・インコーポレイテッド |
p53経路のモディファイヤーとしてのDGKsおよび使用方法
|
|
DE60237917D1
(de)
|
2001-06-05 |
2010-11-18 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
AU2002347428A1
(en)
|
2001-06-18 |
2003-01-02 |
Eos Biotechnology Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
US7189507B2
(en)
|
2001-06-18 |
2007-03-13 |
Pdl Biopharma, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
WO2003004989A2
(en)
|
2001-06-21 |
2003-01-16 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
WO2003002717A2
(en)
|
2001-06-28 |
2003-01-09 |
Schering Corporation |
Biological activity of ak155
|
|
WO2003004529A2
(en)
|
2001-07-02 |
2003-01-16 |
Licentia Ltd. |
Ephrin-tie receptor materials and methods
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
WO2003003984A2
(en)
|
2001-07-05 |
2003-01-16 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
|
WO2003055439A2
(en)
|
2001-07-18 |
2003-07-10 |
The Regents Of The University Of California |
Her2/neu target antigen and use of same to stimulate an immune response
|
|
AU2002337657A1
(en)
|
2001-07-25 |
2003-02-17 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
MXPA04001050A
(es)
|
2001-08-03 |
2004-07-08 |
Genentech Inc |
Polipeptidos tacis y br3 y usos de los mismos.
|
|
WO2003016475A2
(en)
|
2001-08-14 |
2003-02-27 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
US20030092013A1
(en)
|
2001-08-16 |
2003-05-15 |
Vitivity, Inc. |
Diagnosis and treatment of vascular disease
|
|
WO2003018621A2
(en)
|
2001-08-23 |
2003-03-06 |
Oxford Biomedica (Uk) Limited |
Genes
|
|
AU2002357643A1
(en)
|
2001-08-29 |
2003-04-14 |
Vanderbilt University |
The human mob-5 (il-24) receptors and uses thereof
|
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
JP2005505271A
(ja)
|
2001-09-06 |
2005-02-24 |
アジェンシス, インコーポレイテッド |
癌の処置および検出において有用なsteap−1と名称が与えられる核酸および対応するタンパク質
|
|
AU2002330039A1
(en)
|
2001-09-17 |
2003-04-01 |
Eos Biotechnology, Inc. |
Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
|
|
IL160933A0
(en)
|
2001-09-18 |
2004-08-31 |
Proteologics Inc |
Methods and compositions for treating ?cap associated diseases
|
|
WO2003024392A2
(en)
|
2001-09-18 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
WO2003025148A2
(en)
|
2001-09-19 |
2003-03-27 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
WO2003026577A2
(en)
|
2001-09-24 |
2003-04-03 |
Seattle Genetics, Inc. |
P-amidobenzylethers in drug delivery agents
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
AU2002327792A1
(en)
|
2001-09-28 |
2003-04-07 |
Bing Yang |
Diagnosis and treatment of diseases caused by mutations in cd72
|
|
WO2003029277A2
(en)
|
2001-10-03 |
2003-04-10 |
Rigel Pharmaceuticals, Inc. |
Modulators of lymphocyte activation and migration
|
|
AU2002362454A1
(en)
|
2001-10-03 |
2003-04-14 |
Origene Technologies, Inc. |
Regulated breast cancer genes
|
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CA2461665A1
(en)
|
2001-10-19 |
2003-05-01 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
|
|
US20030228319A1
(en)
|
2002-04-16 |
2003-12-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
AU2002356858A1
(en)
|
2001-10-24 |
2003-05-06 |
National Jewish Medical And Research Center |
Structure of tall-1 and its cognate receptor
|
|
WO2003055443A2
(en)
|
2001-10-31 |
2003-07-10 |
Alcon, Inc. |
Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
|
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
US20030232350A1
(en)
|
2001-11-13 |
2003-12-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
WO2003043583A2
(en)
|
2001-11-20 |
2003-05-30 |
Seattle Genetics, Inc. |
Treatment of immunological disorders using anti-cd30 antibodies
|
|
WO2003045422A1
(en)
|
2001-11-29 |
2003-06-05 |
Genset S.A. |
Agonists and antagonists of prolixin for the treatment of metabolic disorders
|
|
AU2002349784A1
(en)
|
2001-12-03 |
2003-06-17 |
Asahi Kasei Pharma Corporation |
Nf-kappab activating genes
|
|
CA2469941A1
(en)
|
2001-12-10 |
2003-07-03 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
US20030134790A1
(en)
|
2002-01-11 |
2003-07-17 |
University Of Medicine And Dentistry Of New Jersey |
Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
|
|
US7452675B2
(en)
|
2002-01-25 |
2008-11-18 |
The Queen's Medical Center |
Methods of screening for TRPM4b modulators
|
|
AU2003215365A1
(en)
|
2002-02-21 |
2003-09-09 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
|
US20040258678A1
(en)
|
2002-02-22 |
2004-12-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20030215849A1
(en)
|
2002-03-01 |
2003-11-20 |
Marcia Belvin |
PDPK1s as modifiers of the p53 pathway and methods of use
|
|
EP2258712A3
(en)
|
2002-03-15 |
2011-05-04 |
Multicell Immunotherapeutics, Inc. |
Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
|
|
CA2486490A1
(en)
|
2002-03-19 |
2003-12-31 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1579186A4
(en)
|
2002-03-21 |
2008-10-08 |
Sunesis Pharmaceuticals Inc |
IDENTIFYING KINASE INHIBITORS
|
|
JP2005520566A
(ja)
|
2002-03-22 |
2005-07-14 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Cripto特異的抗体
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
WO2003089624A2
(en)
|
2002-03-25 |
2003-10-30 |
Uab Research Foundation |
Fc receptor homolog, reagents, and uses thereof
|
|
WO2003083074A2
(en)
|
2002-03-28 |
2003-10-09 |
Idec Pharmaceuticals Corporation |
Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
|
|
US20030194704A1
(en)
|
2002-04-03 |
2003-10-16 |
Penn Sharron Gaynor |
Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
|
|
WO2003087306A2
(en)
|
2002-04-05 |
2003-10-23 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
|
|
US20040101874A1
(en)
|
2002-04-12 |
2004-05-27 |
Mitokor Inc. |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
|
AU2003239158A1
(en)
|
2002-04-17 |
2003-11-03 |
Baylor College Of Medicine |
Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
|
|
AU2003228869A1
(en)
|
2002-05-03 |
2003-11-17 |
Incyte Corporation |
Transporters and ion channels
|
|
AU2003229294A1
(en)
|
2002-05-15 |
2003-12-02 |
Avalon Pharmaceuticals |
Cancer-linked gene as target for chemotherapy
|
|
WO2003101388A2
(en)
|
2002-05-30 |
2003-12-11 |
Bristol-Myers Squibb Company |
Human solute carrier family 7 member 11 (hslc7a11)
|
|
CA2488284A1
(en)
|
2002-06-04 |
2003-12-11 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked gene as target for chemotherapy
|
|
WO2003101283A2
(en)
|
2002-06-04 |
2003-12-11 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
|
WO2003104270A2
(en)
|
2002-06-06 |
2003-12-18 |
Ingenium Pharmaceuticals Ag |
Dudulin 2 genes, expression products, non-human animal model: uses in human hematological disease
|
|
BRPI0311822B8
(pt)
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
composição farmacêutica para o tratamento de câncer
|
|
EP1576111A4
(en)
|
2002-06-07 |
2006-10-18 |
Avalon Pharmaceuticals |
CANCER-ASSOCIATED GENE AS A TARGET FOR CHEMOTHERAPY
|
|
AU2003245441A1
(en)
|
2002-06-12 |
2003-12-31 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked gene as target for chemotherapy
|
|
US20040249130A1
(en)
|
2002-06-18 |
2004-12-09 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
|
US20040022727A1
(en)
|
2002-06-18 |
2004-02-05 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
|
US7304149B2
(en)
|
2002-06-20 |
2007-12-04 |
Washington University In St. Louis |
BTLA nucleic acids
|
|
WO2004001004A2
(en)
|
2002-06-21 |
2003-12-31 |
Johns Hopkins University School Of Medicine |
Membrane associated tumor endothelium markers
|
|
AU2003281515A1
(en)
|
2002-07-19 |
2004-02-09 |
Cellzome Ag |
Protein complexes of cellular networks underlying the development of cancer and other diseases
|
|
CA2492447A1
(en)
|
2002-07-25 |
2004-02-05 |
Genentech, Inc. |
Taci antibodies and uses thereof
|
|
WO2004032828A2
(en)
|
2002-07-31 |
2004-04-22 |
Seattle Genetics, Inc. |
Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
|
|
WO2004015426A1
(en)
|
2002-08-06 |
2004-02-19 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
|
|
JP2004121218A
(ja)
|
2002-08-06 |
2004-04-22 |
Jenokkusu Soyaku Kenkyusho:Kk |
気管支喘息または慢性閉塞性肺疾患の検査方法
|
|
KR20050048615A
(ko)
|
2002-08-19 |
2005-05-24 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
|
WO2004020583A2
(en)
|
2002-08-27 |
2004-03-11 |
Bristol-Myers Squibb Company |
Polynucleotide predictor set for identifying protein tyrosine kinase modulators
|
|
WO2004020595A2
(en)
|
2002-08-29 |
2004-03-11 |
Five Prime Therapeutics, Inc. |
Novel human polypeptides encoded by polynucleotides
|
|
AU2003256038A1
(en)
|
2002-08-30 |
2004-03-19 |
Ramot At Tel Aviv University Ltd. |
Self-immolative dendrimers releasing many active moieties upon a single activating event
|
|
AU2002951346A0
(en)
|
2002-09-05 |
2002-09-26 |
Garvan Institute Of Medical Research |
Diagnosis of ovarian cancer
|
|
MXPA05002455A
(es)
|
2002-09-06 |
2005-06-03 |
Mannkind Corp |
Secuencias de epitopes.
|
|
AU2003300776A1
(en)
|
2002-09-09 |
2004-05-25 |
Omeros Corporation |
G protein coupled receptors and uses thereof
|
|
JP2004113151A
(ja)
|
2002-09-27 |
2004-04-15 |
Sankyo Co Ltd |
癌遺伝子及びその用途
|
|
EP1570078A4
(en)
|
2002-10-04 |
2006-09-13 |
Van Andel Res Inst |
MOLECULAR CLASSIFICATION OF RENAL TUMORS AND DISCOVERING NEW DIAGNOSTIC MARKERS
|
|
EP1581169A4
(en)
|
2002-11-08 |
2008-09-17 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO NATURAL K CELLS
|
|
EP1578940A4
(en)
|
2002-11-13 |
2007-12-12 |
Genentech Inc |
METHOD AND COMPOSITIONS FOR DYSPLASED DIAGNOSIS
|
|
GB0226593D0
(en)
|
2002-11-14 |
2002-12-24 |
Consultants Ltd |
Compounds
|
|
AU2003282624A1
(en)
|
2002-11-14 |
2004-06-03 |
Syntarga B.V. |
Prodrugs built as multiple self-elimination-release spacers
|
|
DK1569685T3
(da)
|
2002-11-15 |
2012-11-12 |
Univ Colorado Regents |
Komplementmodulatorer rettet mod komplementreceptor-2
|
|
WO2004045553A2
(en)
|
2002-11-15 |
2004-06-03 |
The Board Of Trustees Of The University Of Arkansas |
Ca125 gene and its use for diagnostic and therapeutic interventions
|
|
WO2004046342A2
(en)
|
2002-11-20 |
2004-06-03 |
Biogen Idec Inc. |
Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas
|
|
ATE542423T1
(de)
|
2002-11-21 |
2012-02-15 |
Univ Utah Res Found |
Purinerge geruchsmodulation
|
|
WO2004048938A2
(en)
|
2002-11-26 |
2004-06-10 |
Protein Design Labs, Inc. |
Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
|
|
EP1581641A4
(en)
|
2002-12-06 |
2006-11-15 |
Diadexus Inc |
COMPOSITIONS, SPREADING VARIATIONS AND METHODS RELATED TO OVARAL SPECIFIC GENES AND PROTEINS
|
|
JP2004198419A
(ja)
|
2002-12-13 |
2004-07-15 |
Bayer Healthcare Llc |
Timp1を用いた検出方法
|
|
US7276372B2
(en)
|
2002-12-20 |
2007-10-02 |
Pdl Biopharma, Inc. |
Antibodies against GPR64 and uses thereof
|
|
WO2004058309A1
(en)
|
2002-12-23 |
2004-07-15 |
Human Genome Sciences, Inc. |
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof
|
|
WO2004063709A2
(en)
|
2003-01-08 |
2004-07-29 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
|
US20050227301A1
(en)
|
2003-01-10 |
2005-10-13 |
Polgen |
Cell cycle progression proteins
|
|
WO2004063355A2
(en)
|
2003-01-10 |
2004-07-29 |
Protein Design Labs, Inc. |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
|
|
US20040171823A1
(en)
|
2003-01-14 |
2004-09-02 |
Nadler Steven G. |
Polynucleotides and polypeptides associated with the NF-kappaB pathway
|
|
JP2007520996A
(ja)
|
2003-01-15 |
2007-08-02 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
44390、54181、211、5687、884、1405、636、4421、5410、30905、2045、16405、18560、2047、33751、52872、14063、20739、32544、43239、44373、51164、53010、16852、1587、2207、22245、2387、52908、69112、14990、18547、115、579、15985、15625、760、18603、2395、2554、8675、32720、4809、14303、16816、17827、32620、577、619、1423、2158、8263、15402、16209、16386、21165、30911、41897、1643、2543、9626、13231、32409、84260、2882、8203、32678または55053を用いて泌尿器科障害を処置するための方法および組成物
|
|
EP1594893A2
(en)
|
2003-02-14 |
2005-11-16 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
|
US20030224411A1
(en)
|
2003-03-13 |
2003-12-04 |
Stanton Lawrence W. |
Genes that are up- or down-regulated during differentiation of human embryonic stem cells
|
|
CA2520898C
(en)
|
2003-03-31 |
2009-10-20 |
Council Of Scientific And Industrial Research |
Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof
|
|
GB0321295D0
(en)
|
2003-09-11 |
2003-10-15 |
Spirogen Ltd |
Synthesis of protected pyrrolobenzodiazepines
|
|
GB0416511D0
(en)
|
2003-10-22 |
2004-08-25 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
GB0404577D0
(en)
|
2004-03-01 |
2004-04-07 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
PT2270010E
(pt)
|
2004-03-01 |
2012-03-12 |
Spirogen Ltd |
Derivados de 11-hidroxi-5h-pirrolo[2,1-c][1,4]benzodiazepin- 5-ona como intermediários chave para a preparação de pirrolobenzodiazepinas substituídas em c2
|
|
GB0404574D0
(en)
|
2004-03-01 |
2004-04-07 |
Spirogen Ltd |
Amino acids
|
|
GB0404578D0
(en)
|
2004-03-01 |
2004-04-07 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
WO2005085260A1
(en)
|
2004-03-09 |
2005-09-15 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
|
FR2869231B1
(fr)
|
2004-04-27 |
2008-03-14 |
Sod Conseils Rech Applic |
Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
|
|
GB0410725D0
(en)
|
2004-05-13 |
2004-06-16 |
Spirogen Ltd |
Pyrrolobenzodiazepine therapeutic agents
|
|
BRPI0516284A
(pt)
|
2004-09-23 |
2008-09-02 |
Genentech Inc |
anticorpo construìdo com cisteìna, método de selecionar anticorpos, compostos conjugados de droga-anticorpo, composição farmacêutica, método para matar ou inibir a proliferação de células de tumor, métodos de inibir a proliferação celular e o crescimento de células de tumor, artigo manufaturado e método para produzir um composto
|
|
PT1879901E
(pt)
|
2005-04-21 |
2010-03-29 |
Spirogen Ltd |
Pirrolobenzodiazepinas
|
|
GB0508084D0
(en)
*
|
2005-04-21 |
2005-06-01 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
US20070154906A1
(en)
|
2005-10-05 |
2007-07-05 |
Spirogen Ltd. |
Methods to identify therapeutic candidates
|
|
US8637664B2
(en)
|
2005-10-05 |
2014-01-28 |
Spirogen Sarl |
Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease
|
|
HRP20110498T1
(hr)
|
2005-10-07 |
2011-08-31 |
Exelixis |
Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
|
|
SI1813614T1
(sl)
|
2006-01-25 |
2012-01-31 |
Sanofi 174 |
Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
|
|
WO2008050140A2
(en)
|
2006-10-27 |
2008-05-02 |
Spirogen Limited |
Compounds for treatment of parasitic infection
|
|
CA2683568A1
(en)
|
2007-05-08 |
2008-11-20 |
Genentech, Inc. |
Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
|
|
AU2008312457B2
(en)
|
2007-10-19 |
2014-04-17 |
Genentech, Inc. |
Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
|
|
GB0722088D0
(en)
|
2007-11-09 |
2007-12-19 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
GB0722087D0
(en)
|
2007-11-09 |
2007-12-19 |
Spirogen Ltd |
Polyamides
|
|
GB0813432D0
(en)
|
2008-07-22 |
2008-08-27 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
GB0819097D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
CN105198908B
(zh)
|
2009-02-05 |
2019-12-24 |
伊缪诺金公司 |
新型苯并二氮杂*衍生物
|
|
GB201006340D0
(en)
|
2010-04-15 |
2010-06-02 |
Spirogen Ltd |
Synthesis method and intermediates
|
|
CN102933236B
(zh)
|
2010-04-15 |
2014-10-08 |
斯皮罗根有限公司 |
吡咯并苯二氮卓类及其结合物
|
|
CN103068405A
(zh)
*
|
2010-04-15 |
2013-04-24 |
西雅图基因公司 |
靶向吡咯并苯并二氮杂卓结合物
|
|
ES2623057T3
(es)
|
2010-04-15 |
2017-07-10 |
Medimmune Limited |
Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas
|
|
PT2675480T
(pt)
*
|
2011-02-15 |
2019-04-15 |
Immunogen Inc |
Métodos para preparação de conjugados
|
|
CN103987718A
(zh)
|
2011-09-20 |
2014-08-13 |
斯皮罗根有限公司 |
作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓
|
|
CN103998450B
(zh)
|
2011-10-14 |
2017-03-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓
|
|
AU2012322933B2
(en)
|
2011-10-14 |
2017-02-02 |
Medimmune Limited |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
WO2013055987A1
(en)
|
2011-10-14 |
2013-04-18 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2850375C
(en)
|
2011-10-14 |
2019-07-02 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CN103998449A
(zh)
|
2011-10-14 |
2014-08-20 |
斯皮罗根有限公司 |
吡咯并苯并二氮杂卓
|
|
EP2855482B1
(en)
|
2012-04-30 |
2017-03-01 |
MedImmune Limited |
Pyrrolobenzodiazepines
|
|
NZ701478A
(en)
|
2012-04-30 |
2016-08-26 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
PE20150615A1
(es)
|
2012-07-09 |
2015-05-28 |
Genentech Inc |
Inmunoconjugados que comprenden un anticuerpo anti-cd22 ligado a una pirrolobenzodiazepina
|
|
JP2015523380A
(ja)
|
2012-07-09 |
2015-08-13 |
ジェネンテック, インコーポレイテッド |
抗cd79b抗体を含む免疫複合体
|
|
EP2879708A4
(en)
|
2012-08-02 |
2016-03-16 |
Genentech Inc |
ANTIBODY AND ANTI-ETBR IMMUNOCONJUGATES
|
|
CA2885305C
(en)
|
2012-10-12 |
2019-11-12 |
Spirogen Sarl |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
HRP20182129T1
(hr)
|
2012-10-12 |
2019-02-08 |
Adc Therapeutics Sa |
Konjugati protutijelo - pirolobenzodiazepin
|
|
LT2906251T
(lt)
|
2012-10-12 |
2017-12-11 |
Adc Therapeutics Sa |
Pirolobenzodiazepino-anti-cd22 antikūno konjugatai
|
|
CN104703630A
(zh)
|
2012-10-12 |
2015-06-10 |
斯皮罗根有限公司 |
吡咯并苯并二氮杂卓及其结合物
|
|
HRP20180945T1
(hr)
|
2012-10-12 |
2018-08-10 |
Adc Therapeutics Sa |
Konjugati protutijelo-pirolobenzodiazepin
|
|
CA2887896A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-her2 antibody conjugates
|
|
WO2014057118A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
PT2906253T
(pt)
|
2012-10-12 |
2018-11-05 |
Medimmune Ltd |
Conjugados de anticorpo anti-psma de pirrolobenzodiazepina
|
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
|
RS58921B1
(sr)
|
2012-10-12 |
2019-08-30 |
Medimmune Ltd |
Pirolobenzodiazepini i njihovi konjugati
|
|
JP6527466B2
(ja)
|
2012-12-21 |
2019-06-05 |
メドイミューン・リミテッドMedImmune Limited |
増殖性疾患および自己免疫疾患の治療に使用するための非対称ピロロベンゾジアゼピンニ量体
|
|
WO2014096368A1
(en)
|
2012-12-21 |
2014-06-26 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
PL2958944T3
(pl)
|
2013-02-22 |
2019-09-30 |
Abbvie Stemcentrx Llc |
Koniugaty przeciwciało anty-DLL3-PBD i ich zastosowania
|
|
KR102066319B1
(ko)
|
2013-03-13 |
2020-01-14 |
메디뮨 리미티드 |
피롤로벤조디아제핀 및 그의 컨쥬게이트
|
|
WO2014159981A2
(en)
|
2013-03-13 |
2014-10-02 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
NZ710746A
(en)
|
2013-03-13 |
2018-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US20160106861A1
(en)
|
2013-04-26 |
2016-04-21 |
Spirogen Sarl |
Axl antibody-drug conjugate and its use for the treatment of cancer
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US20160256561A1
(en)
|
2013-10-11 |
2016-09-08 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6681838B2
(ja)
|
2013-12-16 |
2020-04-15 |
ジェネンテック, インコーポレイテッド |
ペプチド模倣薬化合物及びその抗体−薬剤複合体
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|